Viewing Study NCT04200092


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-02-12 @ 7:22 AM
Study NCT ID: NCT04200092
Status: COMPLETED
Last Update Posted: 2025-04-10
First Post: 2019-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Staccato® Granisetron Single Dose PK
Sponsor: Alexza Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-11-04
Start Date Type: ACTUAL
Primary Completion Date: 2020-01-10
Primary Completion Date Type: ACTUAL
Completion Date: 2020-01-31
Completion Date Type: ACTUAL
First Submit Date: 2019-11-20
First Submit QC Date: None
Study First Post Date: 2019-12-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-08
Last Update Post Date: 2025-04-10
Last Update Post Date Type: ACTUAL